Metraipolis › archive › dc_f710a2649eab
Blood-Based Inflammatory Markers Are Associated with Treatment Outcomes in Head and Neck Squamous Cell Carcinoma Receiving Anti-PD-1 Therapy: CRP as a… — Europe PMC PMID:41009716
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41009716
- DOI
- 10.3390/ijms26189154
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-09T21:05:49.254Z
- SHA-256 of the archived text
6eef8d9ac808e2a6c5b67576677b145512eceecf746f06be7cf7feb79059e1d6- Stable URL of this page
https://metraipolis.com/documento/dc_f710a2649eab
How to cite
Blood-Based Inflammatory Markers Are Associated with Treatment Outcomes in Head and Neck Squamous Cell Carcinoma Receiving Anti-PD-1 Therapy: CRP as a… — Europe PMC PMID:41009716 — Europe PMC (en), https://europepmc.org/article/MED/41009716 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_f710a2649eab (Metraipolis archive dc_f710a2649eab, sha256 6eef8d9ac808e2a6c5b67576677b145512eceecf746f06be7cf7feb79059e1d6)
BibTeX
@misc{dcf710a2649eab,
title = {Blood-Based Inflammatory Markers Are Associated with Treatment Outcomes in Head and Neck Squamous Cell Carcinoma Receiving Anti-PD-1 Therapy: CRP as a… — Europe PMC PMID:41009716},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41009716},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_f710a2649eab; sha256 6eef8d9ac808e2a6c5b67576677b145512eceecf746f06be7cf7feb79059e1d6},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41009716. Agents can read the archived copy with the MCP tool read_document.